| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatase binding | PSG1 PSG3 PSG4 MAST2 STAT6 PPP1R10 MTMR4 FCRL3 SBF2 PSG8 TMEM225 CABIN1 | 1.61e-07 | 264 | 130 | 12 | GO:0019902 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.13e-06 | 29 | 130 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | PSG1 PSG3 PSG4 STAT6 PPP1R10 MTMR4 FCRL3 PSG8 TMEM225 CABIN1 | 1.19e-06 | 210 | 130 | 10 | GO:0019903 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.63e-06 | 14 | 130 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.38e-05 | 23 | 130 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 3.59e-05 | 29 | 130 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | kinase binding | FOXO3 STUB1 PSG1 PSG3 PSG4 NBEAL1 ROR2 PFKM SIRT1 CCNB1 PTK2B FCRL3 ANKRA2 FBXO7 CDK5RAP1 PRKAR1B PSG8 NBR1 | 5.72e-05 | 969 | 130 | 18 | GO:0019900 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 6.84e-05 | 34 | 130 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 9.34e-05 | 70 | 130 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.14e-04 | 73 | 130 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein kinase binding | FOXO3 PSG1 PSG3 PSG4 NBEAL1 ROR2 SIRT1 CCNB1 PTK2B FCRL3 ANKRA2 FBXO7 CDK5RAP1 PRKAR1B PSG8 NBR1 | 1.78e-04 | 873 | 130 | 16 | GO:0019901 |
| GeneOntologyMolecularFunction | glycolipid binding | 2.90e-04 | 49 | 130 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.01e-04 | 196 | 130 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | CASP8AP2 FLT3 HTR2B PI16 PLEKHG2 SOCS6 ARHGAP11A DENND4C CCNB1 CCNG2 GLMN PPP1R10 ARHGDIB FRY SBF2 PRKAR1B TMEM225 SIPA1L2 CABIN1 CRB2 | 8.43e-04 | 1418 | 130 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 8.65e-04 | 7 | 130 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 8.65e-04 | 7 | 130 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 9.53e-04 | 173 | 130 | 6 | GO:0070851 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 8.16e-09 | 25 | 128 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 SOCS6 ZP3 STAT6 ITPKB GLMN RIF1 FCRL3 BTN2A3P FBXO7 PSG8 VCAM1 | 4.75e-08 | 614 | 128 | 18 | GO:0051249 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | IL12B FLT3 HTR2B STUB1 PSG1 PSG3 PSG4 ROR2 SIRT1 CCNB1 CCNG2 PTK2B TINF2 FBXO7 CDK5RAP1 PRKAR1B LRP5 KDR PSG8 SMG6 | 1.32e-07 | 810 | 128 | 20 | GO:0051338 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.62e-07 | 23 | 128 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 SOCS6 ZP3 STAT6 ITPKB GLMN RIF1 FCRL3 BTN2A3P FBXO7 PSG8 VCAM1 | 2.93e-07 | 694 | 128 | 18 | GO:0002694 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 3.29e-07 | 24 | 128 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.29e-07 | 24 | 128 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.29e-07 | 24 | 128 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | FLT3 HTR2B PSG1 PSG3 PSG4 SIRT1 CCNB1 CCNG2 FBXO7 CDK5RAP1 PRKAR1B LRP5 PSG8 | 3.67e-07 | 358 | 128 | 13 | GO:0071900 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.09e-07 | 25 | 128 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 8.97e-07 | 29 | 128 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 SOCS6 ZP3 STAT6 ITPKB GLMN RIF1 FCRL3 BTN2A3P FBXO7 PSG8 VCAM1 | 1.01e-06 | 756 | 128 | 18 | GO:0050865 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | IL12B PSG1 PSG3 PSG4 ATAD5 ZP3 STAT6 GLMN FCRL3 BTN2A3P PSG8 VCAM1 | 1.11e-06 | 332 | 128 | 12 | GO:0070663 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | IL12B FLT3 HTR2B PSG1 PSG3 PSG4 ROR2 SIRT1 CCNB1 CCNG2 PTK2B FBXO7 CDK5RAP1 PRKAR1B LRP5 KDR PSG8 | 1.21e-06 | 686 | 128 | 17 | GO:0043549 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.35e-06 | 14 | 128 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.83e-06 | 15 | 128 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.83e-06 | 15 | 128 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.83e-06 | 15 | 128 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.83e-06 | 15 | 128 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.90e-06 | 232 | 128 | 10 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.93e-06 | 60 | 128 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.43e-06 | 16 | 128 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | IL12B PSG1 PSG3 PSG4 ATAD5 ZP3 GLMN FCRL3 BTN2A3P PSG8 VCAM1 | 2.85e-06 | 301 | 128 | 11 | GO:0050670 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.16e-06 | 17 | 128 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.16e-06 | 17 | 128 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.16e-06 | 17 | 128 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | IL12B PSG1 PSG3 PSG4 ATAD5 ZP3 GLMN FCRL3 BTN2A3P PSG8 VCAM1 | 3.34e-06 | 306 | 128 | 11 | GO:0032944 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 4.05e-06 | 18 | 128 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 ZP3 STAT6 GLMN FCRL3 BTN2A3P PSG8 VCAM1 | 4.11e-06 | 445 | 128 | 13 | GO:0070661 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.14e-06 | 39 | 128 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | FOXO3 IL12B PSG1 PSG3 PSG4 ETS1 SOCS6 ZP3 ITPKB GLMN BTN2A3P PSG8 VCAM1 | 4.32e-06 | 447 | 128 | 13 | GO:1903037 |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | IL12B FLT3 HTR2B PSG1 PSG3 PSG4 SIRT1 CCNB1 CCNG2 PTK2B FBXO7 CDK5RAP1 PRKAR1B LRP5 PSG8 | 6.02e-06 | 611 | 128 | 15 | GO:0045859 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 6.35e-06 | 20 | 128 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ROR2 ETS1 ITPKB PTK2B FCRL3 BTN2A3P FBXO7 PSG8 | 6.79e-06 | 540 | 128 | 14 | GO:1903706 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 6.89e-06 | 211 | 128 | 9 | GO:0051250 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 ZP3 GLMN FCRL3 BTN2A3P PSG8 VCAM1 | 7.16e-06 | 398 | 128 | 12 | GO:0046651 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 7.80e-06 | 21 | 128 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 7.80e-06 | 21 | 128 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 7.80e-06 | 21 | 128 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 8.05e-06 | 273 | 128 | 10 | GO:0051348 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 ZP3 GLMN FCRL3 BTN2A3P PSG8 VCAM1 | 8.74e-06 | 406 | 128 | 12 | GO:0032943 |
| GeneOntologyBiologicalProcess | lymphocyte activation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 SOCS6 ZP3 STAT6 ITPKB PTK2B GLMN RIF1 FCRL3 BTN2A3P FBXO7 PSG8 VCAM1 | 9.31e-06 | 976 | 128 | 19 | GO:0046649 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 9.49e-06 | 22 | 128 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 1.00e-05 | 221 | 128 | 9 | GO:0006469 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | FOXO3 IL12B PSG1 PSG3 PSG4 ETS1 SOCS6 ZP3 ITPKB GLMN BTN2A3P PSG8 VCAM1 | 1.06e-05 | 486 | 128 | 13 | GO:0007159 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.14e-05 | 23 | 128 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.28e-05 | 288 | 128 | 10 | GO:0045637 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.30e-05 | 49 | 128 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.44e-05 | 50 | 128 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ROR2 ITPKB FCRL3 BTN2A3P FBXO7 PSG8 | 1.52e-05 | 429 | 128 | 12 | GO:1902105 |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 1.69e-05 | 236 | 128 | 9 | GO:0042129 | |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 1.69e-05 | 236 | 128 | 9 | GO:0033673 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 1.93e-05 | 240 | 128 | 9 | GO:0002695 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | IL12B FLT3 HTR2B PSG1 PSG3 PSG4 ROR2 SIRT1 CCNB1 ITPKB CCNG2 PTK2B GLMN MTMR4 FCRL3 FBXO7 CDK5RAP1 PRKAR1B LRP5 KDR PSG8 TMEM225 SMG6 | 1.98e-05 | 1421 | 128 | 23 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | IL12B FLT3 HTR2B PSG1 PSG3 PSG4 ROR2 SIRT1 CCNB1 ITPKB CCNG2 PTK2B GLMN MTMR4 FCRL3 FBXO7 CDK5RAP1 PRKAR1B LRP5 KDR PSG8 TMEM225 SMG6 | 2.02e-05 | 1423 | 128 | 23 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.22e-05 | 27 | 128 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | FOXO3 FLT3 ABCA4 ACACB PSG1 PSG3 PSG4 ETS1 IP6K1 CUBN SIRT1 STAT6 ITPKB PTK2B PACS1 SLC12A3 KDR PSG8 CRB2 | 2.35e-05 | 1043 | 128 | 19 | GO:0048871 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 2.35e-05 | 309 | 128 | 10 | GO:0002703 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.52e-05 | 56 | 128 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.58e-05 | 28 | 128 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 2.68e-05 | 382 | 128 | 11 | GO:0043491 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | FOXO3 IL12B PSG1 PSG3 PSG4 SOCS6 ZP3 ITPKB GLMN BTN2A3P PSG8 VCAM1 | 2.88e-05 | 458 | 128 | 12 | GO:0050863 |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | ACACB PSG1 PSG3 PI16 PSG4 SIRT1 TINF2 FBXO7 CDK5RAP1 PRKAR1B LRP5 PSG8 TMEM225 CRB2 | 2.89e-05 | 615 | 128 | 14 | GO:0043086 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ROR2 SIRT1 STAT6 ITPKB PTK2B FCRL3 BTN2A3P FBXO7 PSG8 VCAM1 | 3.10e-05 | 789 | 128 | 16 | GO:0002521 |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | FOXO3 IL12B PSG1 PSG3 PSG4 ETS1 ZP3 ITPKB BTN2A3P PSG8 VCAM1 | 3.16e-05 | 389 | 128 | 11 | GO:0022409 |
| GeneOntologyBiologicalProcess | energy homeostasis | 3.27e-05 | 144 | 128 | 7 | GO:0097009 | |
| GeneOntologyBiologicalProcess | oocyte development | 3.55e-05 | 99 | 128 | 6 | GO:0048599 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FOXO3 IL12B PCDHGB6 PSG1 PSG3 PSG4 ETS1 SOCS6 ZP3 ITPKB GLMN HMCN2 BTN2A3P LRP5 ASTN1 PSG8 PCDHB1 VCAM1 CRB2 | 3.64e-05 | 1077 | 128 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 3.91e-05 | 31 | 128 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 4.07e-05 | 264 | 128 | 9 | GO:0050866 | |
| GeneOntologyBiologicalProcess | leukocyte activation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 SOCS6 ZP3 STAT6 ITPKB PTK2B GLMN RIF1 FCRL3 FCER2 BTN2A3P FBXO7 PSG8 VCAM1 | 4.20e-05 | 1186 | 128 | 20 | GO:0045321 |
| GeneOntologyBiologicalProcess | oocyte differentiation | 4.44e-05 | 103 | 128 | 6 | GO:0009994 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.45e-05 | 32 | 128 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.45e-05 | 32 | 128 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.45e-05 | 32 | 128 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.54e-05 | 334 | 128 | 10 | GO:0051896 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 4.55e-05 | 405 | 128 | 11 | GO:0033674 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 5.04e-05 | 33 | 128 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 5.04e-05 | 33 | 128 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 5.50e-05 | 107 | 128 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | IL12B FLT3 HTR2B STUB1 PSG1 PSG3 PSG4 ROR2 SIRT1 PTK2B KDR PSG8 | 5.54e-05 | 490 | 128 | 12 | GO:0051347 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 5.68e-05 | 34 | 128 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 5.68e-05 | 34 | 128 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 6.14e-05 | 159 | 128 | 7 | GO:0002821 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | IL12B PSG1 PSG3 PSG4 ATAD5 ZP3 SIRT1 STAT6 RIF1 FCRL3 FCER2 PSG8 | 6.34e-05 | 497 | 128 | 12 | GO:0002697 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 6.38e-05 | 35 | 128 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | FOXO3 IL12B PSG1 PSG3 PSG4 ETS1 ZP3 ITPKB PTK2B BTN2A3P KDR PSG8 VCAM1 | 6.52e-05 | 579 | 128 | 13 | GO:0045785 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | FOXO3 IL12B PSG1 PSG3 PSG4 ETS1 SOCS6 ZP3 ITPKB GLMN BTN2A3P PSG8 VCAM1 | 6.63e-05 | 580 | 128 | 13 | GO:0022407 |
| GeneOntologyBiologicalProcess | T cell proliferation | 7.96e-05 | 288 | 128 | 9 | GO:0042098 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 7.98e-05 | 71 | 128 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | antral ovarian follicle growth | 8.08e-05 | 14 | 128 | 3 | GO:0001547 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 8.50e-05 | 226 | 128 | 8 | GO:0050680 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 8.87e-05 | 38 | 128 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 9.12e-05 | 73 | 128 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 9.48e-05 | 118 | 128 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 9.70e-05 | 171 | 128 | 7 | GO:0050868 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.09e-04 | 40 | 128 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.10e-04 | 76 | 128 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | T cell activation | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 SOCS6 ZP3 STAT6 ITPKB GLMN BTN2A3P PSG8 VCAM1 | 1.17e-04 | 701 | 128 | 14 | GO:0042110 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 1.19e-04 | 375 | 128 | 10 | GO:0001933 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.53e-06 | 16 | 131 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | receptor complex | IL12B FLT3 HTR2B PSG1 PSG3 PSG4 ROR2 CUBN TLR10 PTK2B LRP5 KDR PSG8 NBR1 | 1.74e-05 | 581 | 131 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | external side of plasma membrane | IL12B FLT3 PSG1 PSG3 PSG4 CUBN FCRL3 FCER2 BTN2A3P ASTN1 KDR PSG8 VCAM1 | 2.36e-05 | 519 | 131 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 6.04e-05 | 157 | 131 | 7 | GO:1902554 | |
| GeneOntologyCellularComponent | chromosome, telomeric repeat region | 8.32e-05 | 14 | 131 | 3 | GO:0140445 | |
| GeneOntologyCellularComponent | protein kinase complex | 9.96e-05 | 170 | 131 | 7 | GO:1902911 | |
| GeneOntologyCellularComponent | transferase complex | ACACB STUB1 PSG1 PSG3 PSG4 RNF144A SOCS6 PFKM SIRT1 CCNB1 CCNG2 GLMN BRCA2 UBE3D FBXO7 PRKAR1B PSG8 | 1.10e-04 | 963 | 131 | 17 | GO:1990234 |
| GeneOntologyCellularComponent | chromosome, telomeric region | 1.24e-04 | 176 | 131 | 7 | GO:0000781 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 2.67e-04 | 335 | 131 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | pole plasm | 7.80e-04 | 29 | 131 | 3 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 7.80e-04 | 29 | 131 | 3 | GO:0060293 | |
| GeneOntologyCellularComponent | P granule | 7.80e-04 | 29 | 131 | 3 | GO:0043186 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.00e-03 | 487 | 131 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | side of membrane | IL12B FLT3 PSG1 PSG3 PSG4 CUBN RYR1 FCRL3 FCER2 BTN2A3P ASTN1 KDR PSG8 VCAM1 | 1.19e-03 | 875 | 131 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | chromosomal region | 1.36e-03 | 421 | 131 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | RNA polymerase III transcription regulator complex | 1.36e-03 | 9 | 131 | 2 | GO:0090576 | |
| GeneOntologyCellularComponent | pi-body | 2.07e-03 | 11 | 131 | 2 | GO:0071546 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.48e-03 | 90 | 131 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | inclusion body | 2.48e-03 | 90 | 131 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear telomere cap complex | 2.91e-03 | 13 | 131 | 2 | GO:0000783 | |
| GeneOntologyCellularComponent | telomere cap complex | 2.91e-03 | 13 | 131 | 2 | GO:0000782 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 8.58e-06 | 17 | 112 | 4 | MP:0031047 | |
| MousePheno | abnormal glycogen homeostasis | 2.01e-05 | 144 | 112 | 8 | MP:0005438 | |
| MousePheno | increased skeletal muscle triglyceride level | 2.10e-05 | 21 | 112 | 4 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 3.67e-05 | 24 | 112 | 4 | MP:0014172 | |
| MousePheno | polyphagia | 4.29e-05 | 80 | 112 | 6 | MP:0001433 | |
| MousePheno | increased hemangiosarcoma incidence | 5.10e-05 | 26 | 112 | 4 | MP:0003667 | |
| MousePheno | increased abdominal fat pad weight | 5.94e-05 | 27 | 112 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 6.89e-05 | 28 | 112 | 4 | MP:0020950 | |
| MousePheno | abnormal fatty acid oxidation | 6.98e-05 | 54 | 112 | 5 | MP:0010953 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.04e-04 | 31 | 112 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.04e-04 | 31 | 112 | 4 | MP:0008964 | |
| MousePheno | abnormal skeletal muscle glycogen level | 1.18e-04 | 32 | 112 | 4 | MP:0014069 | |
| MousePheno | abnormal lipid oxidation | 1.26e-04 | 61 | 112 | 5 | MP:0010951 | |
| MousePheno | increased insulin secretion | 1.58e-04 | 64 | 112 | 5 | MP:0003058 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.69e-04 | 35 | 112 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.89e-04 | 36 | 112 | 4 | MP:0031412 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.96e-04 | 67 | 112 | 5 | MP:0004130 | |
| MousePheno | increased skeletal muscle glycogen level | 2.12e-04 | 15 | 112 | 3 | MP:0010401 | |
| MousePheno | decreased respiratory quotient | 2.52e-04 | 110 | 112 | 6 | MP:0010379 | |
| MousePheno | abnormal muscle glycogen level | 2.59e-04 | 39 | 112 | 4 | MP:0014068 | |
| MousePheno | decreased muscle cell glucose uptake | 2.59e-04 | 39 | 112 | 4 | MP:0030022 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 4.04e-04 | 279 | 112 | 9 | MP:0009785 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 4.14e-04 | 44 | 112 | 4 | MP:0031023 | |
| MousePheno | decreased oxygen consumption | 4.24e-04 | 79 | 112 | 5 | MP:0005290 | |
| MousePheno | abnormal insulin secretion | 4.47e-04 | 171 | 112 | 7 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 5.31e-04 | 176 | 112 | 7 | MP:0014195 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 5.34e-04 | 47 | 112 | 4 | MP:0031617 | |
| MousePheno | abnormal respiratory quotient | 5.68e-04 | 178 | 112 | 7 | MP:0004129 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 5.79e-04 | 48 | 112 | 4 | MP:0003567 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 6.27e-04 | 49 | 112 | 4 | MP:0020948 | |
| MousePheno | abnormal cardiovascular development | HTR2B ETS1 CUBN PFKM CASZ1 SIRT1 RYR1 PTK2B GLMN VRTN LRP5 A4GNT KDR ATP11A CRB2 TEDC1 | 6.39e-04 | 802 | 112 | 16 | MP:0002925 |
| MousePheno | abnormal endocrine gland physiology | 6.65e-04 | 363 | 112 | 10 | MP:0013561 | |
| MousePheno | abnormal pancreas secretion | 6.70e-04 | 183 | 112 | 7 | MP:0002694 | |
| MousePheno | abnormal tumor susceptibility | FOXO3 IL12B FLT3 PSG1 PSG3 PSG4 ATAD5 PRDM2 STAT6 BRCA2 BTN2A3P A4GNT ATP11A PSG8 | 6.81e-04 | 650 | 112 | 14 | MP:0002166 |
| MousePheno | increased muscle glycogen level | 6.90e-04 | 22 | 112 | 3 | MP:0031616 | |
| MousePheno | abnormal skeletal muscle morphology | FLT3 ACACB STUB1 PSG1 PSG3 PSG4 GBE1 PFKM RYR1 GYS1 CDK5RAP1 PSG8 | 7.58e-04 | 508 | 112 | 12 | MP:0000759 |
| MousePheno | decreased testis weight | TDRD5 STUB1 ROR2 BTBD18 FAAP100 SIRT1 CFAP65 MOV10L1 SCAPER FBXO7 | 7.70e-04 | 370 | 112 | 10 | MP:0004852 |
| Domain | IGc2 | IL12B PSG1 PSG3 PSG4 ROR2 LRIT3 FCRL3 HMCN2 ALPK3 KDR PSG8 VCAM1 | 8.50e-08 | 235 | 129 | 12 | SM00408 |
| Domain | Ig_sub2 | IL12B PSG1 PSG3 PSG4 ROR2 LRIT3 FCRL3 HMCN2 ALPK3 KDR PSG8 VCAM1 | 8.50e-08 | 235 | 129 | 12 | IPR003598 |
| Domain | Ig-like_fold | PAPPA2 IL12B FLT3 PSG1 PSG3 PSG4 ROR2 GBE1 LRIT3 FCRL3 HMCN2 BTN2A3P ALPK3 ASTN1 KDR PSG8 VCAM1 | 7.37e-06 | 706 | 129 | 17 | IPR013783 |
| Domain | IG_LIKE | IL12B FLT3 PSG1 PSG3 PSG4 ROR2 LRIT3 FCRL3 HMCN2 BTN2A3P ALPK3 KDR PSG8 VCAM1 | 7.71e-06 | 491 | 129 | 14 | PS50835 |
| Domain | Ig-like_dom | IL12B FLT3 PSG1 PSG3 PSG4 ROR2 LRIT3 FCRL3 HMCN2 BTN2A3P ALPK3 KDR PSG8 VCAM1 | 1.01e-05 | 503 | 129 | 14 | IPR007110 |
| Domain | IG | FLT3 PSG1 PSG3 PSG4 ROR2 LRIT3 FCRL3 HMCN2 ALPK3 KDR PSG8 VCAM1 | 3.57e-05 | 421 | 129 | 12 | SM00409 |
| Domain | Ig_sub | FLT3 PSG1 PSG3 PSG4 ROR2 LRIT3 FCRL3 HMCN2 ALPK3 KDR PSG8 VCAM1 | 3.57e-05 | 421 | 129 | 12 | IPR003599 |
| Domain | ig | 5.28e-05 | 190 | 129 | 8 | PF00047 | |
| Domain | Immunoglobulin | 5.28e-05 | 190 | 129 | 8 | IPR013151 | |
| Domain | - | PAPPA2 IL12B FLT3 PSG1 PSG3 PSG4 ROR2 GBE1 LRIT3 FCRL3 ALPK3 ASTN1 KDR PSG8 VCAM1 | 5.40e-05 | 663 | 129 | 15 | 2.60.40.10 |
| Domain | Ig_2 | 1.50e-04 | 73 | 129 | 5 | PF13895 | |
| Domain | DUF1908 | 2.81e-04 | 4 | 129 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.81e-04 | 4 | 129 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.81e-04 | 4 | 129 | 2 | IPR023142 | |
| Domain | - | 2.81e-04 | 4 | 129 | 2 | 1.20.1480.20 | |
| Domain | V-set | 2.92e-04 | 184 | 129 | 7 | PF07686 | |
| Domain | Ig_V-set | 4.69e-04 | 199 | 129 | 7 | IPR013106 | |
| Domain | PROTEIN_KINASE_TYR | 5.64e-04 | 97 | 129 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.64e-04 | 97 | 129 | 5 | IPR008266 | |
| Domain | HECT | 8.34e-04 | 27 | 129 | 3 | PF00632 | |
| Domain | HECTc | 8.34e-04 | 27 | 129 | 3 | SM00119 | |
| Domain | HECT_dom | 8.34e-04 | 27 | 129 | 3 | IPR000569 | |
| Domain | HECT | 8.34e-04 | 27 | 129 | 3 | PS50237 | |
| Domain | IPK | 9.72e-04 | 7 | 129 | 2 | PF03770 | |
| Domain | IPK | 9.72e-04 | 7 | 129 | 2 | IPR005522 | |
| Domain | EGF_3 | 1.24e-03 | 235 | 129 | 7 | PS50026 | |
| Domain | Tyr_kinase_rcpt_3_CS | 1.29e-03 | 8 | 129 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 1.29e-03 | 8 | 129 | 2 | PS00240 | |
| Domain | EGF-like_dom | 1.73e-03 | 249 | 129 | 7 | IPR000742 | |
| Domain | EGF_1 | 1.98e-03 | 255 | 129 | 7 | PS00022 | |
| Domain | Pkinase_Tyr | 2.02e-03 | 129 | 129 | 5 | PF07714 | |
| Domain | CAP_GLY | 2.05e-03 | 10 | 129 | 2 | PF01302 | |
| Domain | CAP_GLY | 2.05e-03 | 10 | 129 | 2 | SM01052 | |
| Domain | - | 2.05e-03 | 10 | 129 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 2.05e-03 | 10 | 129 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 2.05e-03 | 10 | 129 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 2.05e-03 | 10 | 129 | 2 | IPR000938 | |
| Domain | Ig_I-set | 2.07e-03 | 190 | 129 | 6 | IPR013098 | |
| Domain | I-set | 2.07e-03 | 190 | 129 | 6 | PF07679 | |
| Domain | EGF-like_CS | 2.26e-03 | 261 | 129 | 7 | IPR013032 | |
| Domain | EGF_2 | 2.46e-03 | 265 | 129 | 7 | PS01186 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.71e-03 | 138 | 129 | 5 | IPR001245 | |
| Domain | WWE | 2.99e-03 | 12 | 129 | 2 | PF02825 | |
| Domain | ABC_A | 2.99e-03 | 12 | 129 | 2 | IPR026082 | |
| Domain | WWE-dom | 2.99e-03 | 12 | 129 | 2 | IPR004170 | |
| Domain | WWE | 2.99e-03 | 12 | 129 | 2 | PS50918 | |
| Domain | Tyr_kinase_cat_dom | 3.24e-03 | 88 | 129 | 4 | IPR020635 | |
| Domain | TyrKc | 3.24e-03 | 88 | 129 | 4 | SM00219 | |
| Domain | Myotubularin-like_Pase_dom | 4.08e-03 | 14 | 129 | 2 | IPR010569 | |
| Domain | SEA | 4.08e-03 | 14 | 129 | 2 | SM00200 | |
| Domain | PPASE_MYOTUBULARIN | 4.08e-03 | 14 | 129 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 4.08e-03 | 14 | 129 | 2 | IPR030564 | |
| Domain | Myotub-related | 4.08e-03 | 14 | 129 | 2 | PF06602 | |
| Domain | EGF_CA | 4.93e-03 | 99 | 129 | 4 | PS01187 | |
| Domain | DENN | 5.33e-03 | 16 | 129 | 2 | SM00799 | |
| Domain | DENN | 5.33e-03 | 16 | 129 | 2 | PF02141 | |
| Domain | dDENN | 5.33e-03 | 16 | 129 | 2 | PF03455 | |
| Domain | UDENN | 5.33e-03 | 16 | 129 | 2 | PS50946 | |
| Domain | DDENN | 5.33e-03 | 16 | 129 | 2 | PS50947 | |
| Domain | dDENN | 5.33e-03 | 16 | 129 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.33e-03 | 16 | 129 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.33e-03 | 16 | 129 | 2 | IPR005113 | |
| Domain | DENN | 5.33e-03 | 16 | 129 | 2 | PS50211 | |
| Domain | DENN_dom | 5.33e-03 | 16 | 129 | 2 | IPR001194 | |
| Domain | EGF | 5.86e-03 | 235 | 129 | 6 | SM00181 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 BDP1 HIVEP2 RNF144A ROR2 TRPS1 HUWE1 PLD3 ZP3 CASZ1 ITPKB RANBP17 CCNG2 PACS1 INTS6 TNRC18 GTF3C1 SBF2 NAV1 CDK5RAP1 PRKAR1B LRP5 ATP11A SPIDR NBR1 CREB3L2 SMG6 | 9.22e-12 | 1489 | 131 | 27 | 28611215 |
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 3.51e-08 | 25 | 131 | 5 | 38687251 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.34e-07 | 13 | 131 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.34e-07 | 13 | 131 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.34e-07 | 13 | 131 | 4 | 16638824 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 20044046 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 32150576 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 6265583 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.34e-07 | 13 | 131 | 4 | 12832451 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.34e-07 | 13 | 131 | 4 | 21670291 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 22162753 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 2702644 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 8380065 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 1279194 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 25724769 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.34e-07 | 13 | 131 | 4 | 22092845 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 11801635 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.34e-07 | 13 | 131 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.34e-07 | 13 | 131 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.34e-07 | 13 | 131 | 4 | 23800882 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 19285068 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 21760897 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.34e-07 | 13 | 131 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.34e-07 | 13 | 131 | 4 | 39168268 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 8402684 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 16619040 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.34e-07 | 13 | 131 | 4 | 8209741 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.34e-07 | 13 | 131 | 4 | 21949477 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 26219866 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 2133556 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 32521208 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 19406938 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.34e-07 | 13 | 131 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.34e-07 | 13 | 131 | 4 | 19358828 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 16680193 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.34e-07 | 13 | 131 | 4 | 34058224 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 10964771 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 32169849 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.34e-07 | 13 | 131 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.34e-07 | 13 | 131 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.34e-07 | 13 | 131 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.34e-07 | 13 | 131 | 4 | 23935487 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 15331748 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.34e-07 | 13 | 131 | 4 | 22406619 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.34e-07 | 13 | 131 | 4 | 25972571 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 19008452 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.34e-07 | 13 | 131 | 4 | 15220458 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 18843289 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 15207636 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 21081647 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 11133662 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 11483763 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 2164599 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 29396368 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 18003729 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.34e-07 | 13 | 131 | 4 | 33352461 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 38381498 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 20739537 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.34e-07 | 13 | 131 | 4 | 27695943 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 20404914 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.34e-07 | 13 | 131 | 4 | 32027621 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.34e-07 | 13 | 131 | 4 | 27777319 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 18848945 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.87e-07 | 14 | 131 | 4 | 34666041 | |
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.87e-07 | 14 | 131 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.87e-07 | 14 | 131 | 4 | 32209360 | |
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 11994468 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 11850617 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.87e-07 | 14 | 131 | 4 | 26196244 | |
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 8896983 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 22962327 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 17623671 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.87e-07 | 14 | 131 | 4 | 18794798 | |
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 23469261 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 18454175 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 22159884 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 29907459 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 36719377 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 23780386 | ||
| Interaction | PSG4 interactions | 1.10e-07 | 8 | 129 | 4 | int:PSG4 | |
| Interaction | ASF1A interactions | BDP1 CASP8AP2 ATAD5 TRPS1 CASZ1 PRDM2 RIF1 GTF3C1 BRCA2 CABIN1 | 4.70e-06 | 249 | 129 | 10 | int:ASF1A |
| Interaction | PSG1 interactions | 1.84e-05 | 51 | 129 | 5 | int:PSG1 | |
| Cytoband | 19q13.2 | 8.19e-06 | 164 | 131 | 6 | 19q13.2 | |
| Cytoband | 1q25.2 | 9.63e-05 | 31 | 131 | 3 | 1q25.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.02e-07 | 11 | 92 | 4 | 1315 | |
| GeneFamily | Immunoglobulin like domain containing | 5.77e-05 | 193 | 92 | 7 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.72e-04 | 161 | 92 | 6 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.78e-04 | 394 | 92 | 9 | 471 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.10e-03 | 40 | 92 | 3 | 321 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.47e-03 | 163 | 92 | 5 | 590 | |
| GeneFamily | ATP binding cassette subfamily A | 2.24e-03 | 14 | 92 | 2 | 805 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.58e-03 | 15 | 92 | 2 | 903 | |
| GeneFamily | CD molecules|Mucins | 5.05e-03 | 21 | 92 | 2 | 648 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 8.00e-07 | 35 | 130 | 5 | MM757 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 4.82e-06 | 87 | 130 | 6 | MM851 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 6.56e-06 | 197 | 130 | 8 | M12824 | |
| Coexpression | MANALO_HYPOXIA_UP | 8.77e-06 | 205 | 130 | 8 | M259 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.87e-05 | 32 | 130 | 4 | MM2 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.96e-05 | 300 | 130 | 9 | M8702 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 2.02e-05 | 230 | 130 | 8 | MM986 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 3.33e-05 | 180 | 130 | 7 | M6878 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 3.57e-05 | 182 | 130 | 7 | MM993 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.63e-05 | 75 | 130 | 5 | MM605 | |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | HIVEP2 TRPS1 TACC2 SIRT1 PRDM2 INTS6 FRY NDEL1 TESK2 NBR1 FILIP1L | 5.10e-05 | 512 | 130 | 11 | M4508 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 5.53e-05 | 195 | 130 | 7 | M7310 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 6.29e-05 | 199 | 130 | 7 | M4567 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP | 6.29e-05 | 199 | 130 | 7 | M5187 | |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN | 6.49e-05 | 200 | 130 | 7 | M391 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 6.49e-05 | 200 | 130 | 7 | M9777 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 6.49e-05 | 200 | 130 | 7 | M6254 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP | 6.49e-05 | 200 | 130 | 7 | M6606 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 HIVEP2 GBE1 SOCS6 MED13L ARHGAP11A MAST2 TRIP12 CEP350 RIF1 BRCA2 SPIDR FILIP1L CREB3L2 | 9.28e-05 | 856 | 130 | 14 | M4500 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 9.49e-05 | 48 | 130 | 4 | MM531 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 1.08e-04 | 463 | 130 | 10 | MM1011 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.14e-04 | 219 | 130 | 7 | MM3826 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 1.43e-04 | 227 | 130 | 7 | M18441 | |
| Coexpression | GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN | 1.74e-04 | 56 | 130 | 4 | M19492 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.84e-04 | 166 | 130 | 6 | M6826 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.03e-04 | 169 | 130 | 6 | M39230 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 2.16e-04 | 171 | 130 | 6 | M40134 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 185 | 130 | 7 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.92e-06 | 126 | 130 | 6 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 142 | 130 | 6 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 178 | 130 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 178 | 130 | 6 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 178 | 130 | 6 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 179 | 130 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 181 | 130 | 6 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 181 | 130 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 181 | 130 | 6 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-05 | 185 | 130 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | IPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 1.80e-05 | 186 | 130 | 6 | d0d3953d9b199e0e792990b8551efb993393fe7e | |
| ToppCell | IPF-Myeloid-DC_Mature|IPF / Disease state, Lineage and Cell class | 1.85e-05 | 187 | 130 | 6 | 63e0304a0183b69aebb0d1a4640a506a0d6fb6e9 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.15e-05 | 192 | 130 | 6 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.21e-05 | 193 | 130 | 6 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.21e-05 | 193 | 130 | 6 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.41e-05 | 196 | 130 | 6 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | B_cells-Memory_B_cells|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.48e-05 | 197 | 130 | 6 | cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Control-B_naive-9|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.07e-05 | 123 | 130 | 5 | 36d509eae874733f1a4f8189ad3000136ff6425e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-05 | 132 | 130 | 5 | 295980f70645ee2934145e9959c01f999044da3e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.49e-05 | 156 | 130 | 5 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.78e-05 | 157 | 130 | 5 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.78e-05 | 157 | 130 | 5 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 158 | 130 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.04e-04 | 159 | 130 | 5 | ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 1.07e-04 | 160 | 130 | 5 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 161 | 130 | 5 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 162 | 130 | 5 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 163 | 130 | 5 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 1.20e-04 | 164 | 130 | 5 | 334f376350c9cf92611d0f75b2e18a102f4c116a | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 165 | 130 | 5 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 167 | 130 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 167 | 130 | 5 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 171 | 130 | 5 | 4c36d0bf5fa3ddc2144f60769bb288ca4e4e20bc | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 171 | 130 | 5 | 6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 171 | 130 | 5 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 171 | 130 | 5 | c5c1d23b4040a78991512bfcbe046c51f202d2cf | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.50e-04 | 172 | 130 | 5 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 173 | 130 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | b41e975e8368e2618b015be095efe8c0e001c78b | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | 15d1de38e4f1a0d4a786d83ee92240f44bdff006 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 1.81e-04 | 179 | 130 | 5 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 179 | 130 | 5 | 10c7d371937d9d93c12c8d3465430ef9e0c2ec81 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 1.85e-04 | 180 | 130 | 5 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.85e-04 | 180 | 130 | 5 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-04 | 180 | 130 | 5 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 1.90e-04 | 181 | 130 | 5 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 181 | 130 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-04 | 181 | 130 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 181 | 130 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 184 | 130 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-04 | 184 | 130 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.05e-04 | 184 | 130 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.05e-04 | 184 | 130 | 5 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 185 | 130 | 5 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 185 | 130 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 185 | 130 | 5 | e0c9e92e35fb24351f5347a0768e6aab5add8775 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 185 | 130 | 5 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 185 | 130 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 186 | 130 | 5 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 186 | 130 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 186 | 130 | 5 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-04 | 186 | 130 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 187 | 130 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 187 | 130 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.27e-04 | 188 | 130 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 188 | 130 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 2.27e-04 | 188 | 130 | 5 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.27e-04 | 188 | 130 | 5 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 188 | 130 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 188 | 130 | 5 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 188 | 130 | 5 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.27e-04 | 188 | 130 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 2.32e-04 | 189 | 130 | 5 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-04 | 189 | 130 | 5 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.32e-04 | 189 | 130 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 190 | 130 | 5 | 2ff4b50b864a35f22c558d7d585cd2b54612b50c | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 190 | 130 | 5 | 86ab845a7fae2111c0b01e1aec235e19c4c0ef5c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.38e-04 | 190 | 130 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 190 | 130 | 5 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 190 | 130 | 5 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 190 | 130 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 190 | 130 | 5 | 5175bf022d55a52988014abe7cece326a8406a38 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 190 | 130 | 5 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 190 | 130 | 5 | 29e60b9b1c86b44550619c01306b8b1bb2e340dc | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-04 | 191 | 130 | 5 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-04 | 191 | 130 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-04 | 191 | 130 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-04 | 192 | 130 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 2.50e-04 | 192 | 130 | 5 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 2.50e-04 | 192 | 130 | 5 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.50e-04 | 192 | 130 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 2.50e-04 | 192 | 130 | 5 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | Mild/Remission-B_naive-11|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.50e-04 | 192 | 130 | 5 | c6f325cddce43b72f013b21dfffc9987fd68b6a7 | |
| ToppCell | Endothelial|World / shred on cell class and cell subclass (v4) | 2.50e-04 | 192 | 130 | 5 | 2b13cca5c4b58628dbbbb356859632dba66d43f9 | |
| Computational | Neighborhood of CDKN1C | 3.97e-05 | 27 | 78 | 4 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 7.91e-05 | 32 | 78 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.13e-04 | 35 | 78 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 2.33e-04 | 42 | 78 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 3.32e-04 | 46 | 78 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 4.24e-04 | 49 | 78 | 4 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.59e-04 | 50 | 78 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | HECTD3 MRM1 RANBP17 CCNG2 PACS1 ARHGDIB MAST4 SCAPER PRKAR1B | 2.16e-06 | 197 | 131 | 9 | 3532_DN |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | 1.83e-05 | 196 | 131 | 8 | 6571_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 131 | 8 | 1698_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 131 | 8 | 2810_UP | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.97e-05 | 198 | 131 | 8 | 4605_DN | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 199 | 131 | 8 | 5538_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.04e-05 | 199 | 131 | 8 | 2878_DN | |
| Disease | urate measurement, bone density | CASP8AP2 ETS1 GBE1 CASZ1 ITPKB RANBP17 MAST4 MOV10L1 MIPEP NAV1 PRKAR1B CABIN1 | 1.84e-05 | 619 | 129 | 12 | EFO_0003923, EFO_0004531 |
| Disease | cD177 antigen measurement | 6.35e-05 | 18 | 129 | 3 | EFO_0021866 | |
| Disease | monocyte count | FLT3 PSG1 TRPS1 ETS1 MED13L MAST2 CASZ1 RYR1 PTK2B GLMN PPP1R10 BTN2A3P SPIDR CABIN1 VCAM1 CREB3L2 SMG6 | 6.46e-05 | 1320 | 129 | 17 | EFO_0005091 |
| Disease | neurilemmoma (is_marker_for) | 1.88e-04 | 5 | 129 | 2 | DOID:3192 (is_marker_for) | |
| Disease | Familial Exudative Vitreoretinopathy | 1.88e-04 | 5 | 129 | 2 | C0339539 | |
| Disease | interstitial lung disease | 2.16e-04 | 67 | 129 | 4 | EFO_0004244 | |
| Disease | Glycogen Storage Disease | 2.21e-04 | 27 | 129 | 3 | C0017919 | |
| Disease | isobutyrylcarnitine measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0021023 | |
| Disease | Experimental Autoimmune Encephalomyelitis | 6.69e-04 | 9 | 129 | 2 | C0014072 | |
| Disease | hippocampal CA4 volume | 7.71e-04 | 41 | 129 | 3 | EFO_0009396 | |
| Disease | prostate adenocarcinoma (is_marker_for) | 8.34e-04 | 10 | 129 | 2 | DOID:2526 (is_marker_for) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.02e-03 | 11 | 129 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | meningitis | 1.02e-03 | 11 | 129 | 2 | MONDO_0021108 | |
| Disease | neutrophil count | PAPPA2 FLT3 HIVEP2 PSG1 ETS1 PLEKHG2 MAST2 CASZ1 SIRT1 GTF3C1 FCER2 SBF2 MIPEP BTN2A3P SMG6 | 1.06e-03 | 1382 | 129 | 15 | EFO_0004833 |
| Disease | pulse pressure measurement | PAPPA2 FOXO3 PSG1 NBEAL1 TRPS1 MED13L PFKM MAST2 CASZ1 DENND4C SBF2 NAV1 FILIP1L CREB3L2 SMG6 | 1.14e-03 | 1392 | 129 | 15 | EFO_0005763 |
| Disease | cortical thickness | FOXO3 ABCA4 PSG1 EXD1 NBEAL1 TRPS1 TACC2 MAST2 STN1 MAST4 NAV1 CRB2 SMG6 | 1.21e-03 | 1113 | 129 | 13 | EFO_0004840 |
| Disease | Mitral valve prolapse, response to surgery | 1.22e-03 | 12 | 129 | 2 | EFO_0009951, HP_0001634 | |
| Disease | peak expiratory flow | 1.60e-03 | 498 | 129 | 8 | EFO_0009718 | |
| Disease | Varicose veins | 1.63e-03 | 193 | 129 | 5 | HP_0002619 | |
| Disease | Hamman-Rich syndrome | 1.67e-03 | 14 | 129 | 2 | C0085786 | |
| Disease | obsolete_interleukin-12 subunit B measurement | 1.67e-03 | 14 | 129 | 2 | EFO_0010787 | |
| Disease | red blood cell density measurement | PSG1 TRPS1 PFKM MAST2 CASZ1 STN1 SBF2 FBXO7 PRKAR1B ATP11A SMG6 | 1.71e-03 | 880 | 129 | 11 | EFO_0007978 |
| Disease | lymphocyte:monocyte ratio | 1.71e-03 | 288 | 129 | 6 | EFO_0600088 | |
| Disease | keratinocyte carcinoma | 1.82e-03 | 118 | 129 | 4 | EFO_0010176 | |
| Disease | atopic asthma | 1.86e-03 | 199 | 129 | 5 | EFO_0010638 | |
| Disease | Proteinuria | 1.92e-03 | 15 | 129 | 2 | HP_0000093 | |
| Disease | asthma, Eczema, allergic rhinitis | 2.00e-03 | 121 | 129 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | Dyskeratosis Congenita | 2.19e-03 | 16 | 129 | 2 | C0265965 | |
| Disease | Atherosclerosis | 2.22e-03 | 59 | 129 | 3 | C0004153 | |
| Disease | Atherogenesis | 2.22e-03 | 59 | 129 | 3 | C1563937 | |
| Disease | reticulocyte measurement | FOXO3 PSG1 TRPS1 IP6K1 PFKM PACS1 TESK2 SBF2 LPIN2 LRP5 ATP11A SMG6 | 2.29e-03 | 1053 | 129 | 12 | EFO_0010700 |
| Disease | Glycogen storage disease | 2.47e-03 | 17 | 129 | 2 | cv:C0017919 | |
| Disease | Uremia | 2.47e-03 | 17 | 129 | 2 | C0041948 | |
| Disease | iritis | 2.47e-03 | 17 | 129 | 2 | EFO_1000997 | |
| Disease | Van Buchem disease | 2.47e-03 | 17 | 129 | 2 | C0432272 | |
| Disease | vital capacity | THOC1 PAPPA2 FOXO3 HIVEP2 ATAD5 ETS1 TRIP12 CASZ1 STN1 VRTN KDR FILIP1L SMG6 | 3.02e-03 | 1236 | 129 | 13 | EFO_0004312 |
| Disease | visual perception measurement | 3.04e-03 | 223 | 129 | 5 | EFO_0009700 | |
| Disease | histidine measurement | 3.06e-03 | 66 | 129 | 3 | EFO_0009769 | |
| Disease | Usual Interstitial Pneumonia | 3.09e-03 | 19 | 129 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 3.09e-03 | 19 | 129 | 2 | C4721508 | |
| Disease | glomerulonephritis (is_marker_for) | 3.09e-03 | 19 | 129 | 2 | DOID:2921 (is_marker_for) | |
| Disease | squamous cell carcinoma | 3.19e-03 | 67 | 129 | 3 | EFO_0000707 | |
| Disease | seborrheic dermatitis | 3.42e-03 | 20 | 129 | 2 | EFO_1000764 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.42e-03 | 20 | 129 | 2 | C4721952 | |
| Disease | Headache, HbA1c measurement | 3.77e-03 | 21 | 129 | 2 | EFO_0004541, HP_0002315 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.77e-03 | 21 | 129 | 2 | C1800706 | |
| Disease | impotence (biomarker_via_orthology) | 4.14e-03 | 22 | 129 | 2 | DOID:1875 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MATEAPPCVTTEVPS | 276 | Q6UXB8 | |
| DEIPTGMPCLESVTI | 721 | Q8NAT2 | |
| CTMPLVEDTPSSPLV | 516 | Q96KV6 | |
| EIPDSTMSICVPSET | 281 | Q96QE3 | |
| CSPLPTSTMSPEEVE | 556 | Q86US8 | |
| DETPCSSPEKVAMLD | 271 | P41595 | |
| MLSVAPVASSETGPC | 2201 | A6H8Y1 | |
| PICMETTGTTCDLPQ | 51 | Q8TC20 | |
| STREKLTMLPECPEG | 1491 | P78363 | |
| MDLGTAEGTRCTDPP | 1 | Q86V15 | |
| ETSERMEPPHLVSCS | 56 | Q9UNA3 | |
| PGEVLECQTTTAPTM | 751 | Q96L96 | |
| MSCGEESLSSSPPSD | 311 | Q16589 | |
| SLEMVECVGTLDPAT | 2066 | Q8IYW2 | |
| DILLLDEPSSGMDPC | 4876 | Q86UQ4 | |
| EECPSTYSLTGMPDI | 16 | Q9H9E1 | |
| VIFSISAAPMPSDCE | 31 | Q8N3C7 | |
| EEPICGTETSFPSPM | 671 | Q9UKL3 | |
| SAPDMRVALSSCVPD | 546 | Q8TCP9 | |
| DDIISGAKSPCAMPS | 1091 | O14525 | |
| CEMSDSGSQVPDSLP | 1381 | Q6ZS30 | |
| GEPTCTTPILKLMAE | 761 | Q9H2T7 | |
| LTGVPLDDSAITPMC | 186 | Q9UL03 | |
| LDDSAITPMCEVTGG | 191 | Q9UL03 | |
| NEDMVCSVSPGALIP | 776 | Q9Y5F9 | |
| DTGPPSLSAETMIEV | 426 | Q9Y5F3 | |
| MPEIVDTCSLASPAS | 1 | P09960 | |
| VECLPSIPLGTMSTI | 526 | Q86VD1 | |
| MLIDELCGPDPSLSD | 1186 | O00763 | |
| ETPMEICLNGTPALA | 276 | Q8IV08 | |
| DSPSILSACLVAMEP | 1941 | Q71F56 | |
| ASEPECLIPLGLMSD | 891 | Q9BXT6 | |
| LMRACIPSTIPTDSE | 1356 | Q86WG5 | |
| LTAGCVSEDMCSPDP | 801 | Q5IJ48 | |
| TELSLTPGAPMELLC | 3511 | Q8NDA2 | |
| EGSMPPRSQDTICLT | 1051 | Q6ZU64 | |
| GGTEPTCMELPEELL | 291 | Q8NHP7 | |
| DELMCEITKPPSDDS | 1366 | O75197 | |
| SPDMECADVPLLTPS | 26 | P14921 | |
| TIVPASPTDPCVEMD | 2776 | Q02505 | |
| SPTDPCVEMDPSTEA | 2781 | Q02505 | |
| CVEMDPSTEATSPPT | 2786 | Q02505 | |
| VMALLEGTPDTPACV | 321 | P08237 | |
| RCPLVPESAAGSTMD | 91 | Q5TGS1 | |
| ATCTPPASEGSAESM | 286 | P06734 | |
| LDPLMTCSEPERLTG | 226 | Q3SXY7 | |
| TCSLDLDSEMPGPAR | 431 | Q0VG06 | |
| APGEMVVLTCDTPEE | 41 | P29460 | |
| ACVSMLGVPVDPDTL | 1761 | Q7Z6Z7 | |
| TSLHMCDGRTPTPEE | 206 | O60243 | |
| LPASSPCTLGEENMD | 571 | Q9NYA4 | |
| SGPEMEETESILSTP | 381 | Q6VY07 | |
| CPETMPITFLPGETS | 156 | P50876 | |
| DPCKETVPSMETGDL | 756 | Q9BXP8 | |
| MLCGSDIEPPIGSLE | 501 | B2RXH4 | |
| ATVCGDEMPAPLTIA | 2996 | O60494 | |
| SSYPMVSESPEDLGC | 51 | P36888 | |
| LVDTASPSPMETSGC | 121 | P14635 | |
| AEDVSGMPALCSPIS | 411 | Q04446 | |
| PVEPSALCSDSVMEP | 1366 | Q9Y2F5 | |
| GPTEPMDTSEATVCH | 1756 | Q9Y6J0 | |
| SPDACTPLEAPESLM | 2761 | P51587 | |
| CESAPGPITMDLTGD | 76 | P52566 | |
| TPESCGSLTPERTMS | 986 | Q4L180 | |
| SEPMLCSESVEGQVP | 166 | Q9Y3I1 | |
| SFELMREPCITPSGI | 236 | Q9UNE7 | |
| EPLDTSVESMLPDCP | 351 | Q8WUF8 | |
| SVESMLPDCPRVSAG | 356 | Q8WUF8 | |
| PGSPDHSILTEEMIC | 1966 | Q5VT06 | |
| SESDVPLFCLPMGAT | 226 | Q5VZ89 | |
| PIEGSPMTLTCETQL | 201 | Q96P31 | |
| DPLEEMAQLSSCDSP | 471 | Q6P0Q8 | |
| PSMELCFPETAKTSD | 1996 | O15021 | |
| LDMVLPEVASSCGPS | 361 | Q92551 | |
| MASPPACPSEEDESL | 1 | P31321 | |
| PMELLTTACDSTPAE | 2551 | Q5TBA9 | |
| EGLCASSPTLTSPME | 741 | Q14289 | |
| PAECTVMGIPSISTN | 516 | P13807 | |
| AMEAVILTCDPATPA | 161 | Q00888 | |
| DTECVSVMLQAGTPP | 376 | Q9BY12 | |
| PSSVEDTMSLLECLG | 2146 | P21817 | |
| EEPPLEMNTGVDSSC | 156 | Q70SY1 | |
| TMEAVSLTCDPETPD | 161 | P11464 | |
| KAETDSDPMVPSCSL | 651 | Q13029 | |
| VFDMLTPTTGLECEP | 1461 | Q3ZCN5 | |
| DMEAVSLTCDPETPD | 161 | Q16557 | |
| PTDPCVEMDPSTEAT | 696 | Q9H195 | |
| PMDGISTCGPKEEVT | 1406 | Q8NEY1 | |
| PCTVELPRLTDMAGT | 361 | O43524 | |
| LCSITVSGEEIPNMP | 536 | Q92990 | |
| EPDIMVEKSPATSCE | 551 | Q6P4F7 | |
| MQPGSSRCEEETPSL | 1 | Q9H668 | |
| SVTMTCSSEGLPAPE | 241 | P19320 | |
| CSIVMTAEGDAPELP | 11 | Q9BXR5 | |
| AGMSIIPTFPEILSC | 346 | Q6NT16 | |
| CPSEVSMPTSEETLF | 191 | Q14596 | |
| ISEMAKESIPCPTES | 2276 | Q5UIP0 | |
| CSPSNIPAVIITDMG | 561 | P27987 | |
| EDPQSSEIPIMSCLE | 231 | Q6IN84 | |
| AMEAVSLTCDPETPD | 161 | Q9UQ74 | |
| ASTDSGIDTAPCMPA | 1261 | Q9P2F8 | |
| DSGTCQSPSLEEPME | 676 | Q96EB6 | |
| LESESMSPGDPCSSR | 1001 | Q6ZUB1 | |
| MELCDVPSCSPRDSS | 386 | Q01974 | |
| VLPESSGIDMIDSSP | 446 | P98196 | |
| LSSTMCPSPERQEDG | 36 | Q96SZ6 | |
| GEAMEICSEPVAASP | 201 | Q8NB15 | |
| SPILPGMVCTSAVGE | 456 | Q2L4Q9 | |
| ESQPTLEMSDCDVPA | 1286 | O15417 | |
| PQDMACTPSGDSLET | 136 | Q9UHF7 | |
| CPVSEMFGRLSPVSE | 56 | Q6ZQT0 | |
| SPVSEMFGRLCPVSE | 106 | Q6ZQT0 | |
| TRCPTDFAEVPSILM | 516 | Q99797 | |
| SGASSCELPGPVMLD | 751 | Q14159 | |
| CELPGPVMLDSLDSA | 756 | Q14159 | |
| SPDPLLCSDVTMVED | 756 | P42226 | |
| PECSVTDSVNLAEPM | 201 | Q9BSI4 | |
| PSSLQMKTPEGCTEI | 41 | Q7Z6J8 | |
| MDTVLGTCAPEVPAA | 326 | Q86SX3 | |
| EPPLGSCSDVMLSVE | 566 | P28908 | |
| MAELPTTETPGDATL | 1 | P55017 | |
| ARTTEGPVDSMPCLD | 1316 | O95359 | |
| MSESPTPCSGSSFEE | 2566 | O95359 | |
| NSIEDISLPECTAMP | 186 | Q6GV28 | |
| LPSLSDISDVFEMPC | 656 | Q9H7P9 | |
| MEEDSGLSLPTSPVS | 1186 | P35968 | |
| GLSLPTSPVSCMEEE | 1191 | P35968 | |
| AAAPLEELTMGTSCL | 1691 | Q12789 | |
| TSPCPAGASEEMEVE | 531 | Q96S53 | |
| SLCSEESPEMTSLPP | 136 | Q9H8Y1 | |
| EEDTPMICSSIVSTP | 706 | P31629 | |
| TENPDDFLPSVMTCV | 1946 | Q14669 | |
| CSMDETPYVETLEPG | 526 | Q96QC0 | |
| LTLGPEACEPLVSMD | 71 | P21754 | |
| CLDSSSPMEVSAVPP | 241 | O14544 | |
| DSGVPEPAVCMVTTA | 341 | Q2M3C6 | |
| EMGDEEAPTTCSIPI | 216 | Q96FV9 | |
| MSEELCPSSADTPVP | 551 | Q5T447 | |
| CRMSGEFPSPVSISI | 441 | Q3SY84 | |
| DSAMDLPDVTLSLCG | 461 | Q92539 | |
| PSSPTLDCEKMDSAV | 196 | Q9GZM8 |